These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6207981)

  • 1. The brain renin angiotensin system in central cardiovascular control.
    Ganten D; Paul M; Deboben A; Unger T; Lang RE
    Contrib Nephrol; 1984; 43():114-28. PubMed ID: 6207981
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of renin: recent developments.
    Hofbauer KG; Wood JM
    Contrib Nephrol; 1984; 43():144-52. PubMed ID: 6207982
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibitors of the renin-angiotensin system as new antihypertensive agents.
    Antonaccio MJ
    Clin Exp Hypertens A; 1982; 4(1-2):27-46. PubMed ID: 6176373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme blockade by Captopril changes angiotensin II receptors and angiotensinogen concentrations in the brain of SHR-sp and WKY rats.
    Felix D; Schelling P
    Neurosci Lett; 1982 Dec; 34(1):45-50. PubMed ID: 6298670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of captopril treatment on angiotensin II receptors and angiotensinogen in the brain of spontaneously hypertensive rats.
    Schelling P; Felix D
    Hypertension; 1983; 5(6):935-42. PubMed ID: 6317552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of converting enzyme inhibition and angiotensin receptor blockade on the vasoconstriction mediated by alpha 1-and alpha 2-adrenoceptor stimulation in pithed normotensive rats.
    de Jonge A; Knape JT; van Meel JC; Kalkman HO; Wilffert B; Thoolen MJ; Timmermanns PB; van Zwieten PA
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec; 321(4):309-13. PubMed ID: 6188064
    [No Abstract]   [Full Text] [Related]  

  • 7. [Renin-angiotensin system inhibitors - biochemical and clinical aspects].
    Kuska J; Germakowska-Kowalik T; Pluta S
    Postepy Hig Med Dosw; 1982; 35(4):395-411. PubMed ID: 6183653
    [No Abstract]   [Full Text] [Related]  

  • 8. Regional distribution of renin and angiotensinogen in the brain of normotensive (WKY) and spontaneously hypertensive (SHR) rats.
    Naruse M; Naruse K; McKenzie JC; Schelling P; Inagami T
    Brain Res; 1985 Apr; 333(1):147-50. PubMed ID: 3888347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of activation and blockade of the renin-angiotensin system on the hypotensive activity of the cholinergic system].
    Fedorov VI
    Fiziol Zh SSSR Im I M Sechenova; 1992 May; 78(5):33-40. PubMed ID: 1334879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine mechanisms in the pathogenesis of essential hypertension. VI. Blockade of the renin-angiotensin system as a therapeutical basis.
    Păuşescu E
    Physiologie; 1982; 19(4):245-64. PubMed ID: 6185963
    [No Abstract]   [Full Text] [Related]  

  • 11. Interaction of angiotensin-converting enzyme inhibitors with the function of the sympathetic nervous system.
    Clough DP; Collis MG; Conway J; Hatton R; Keddie JR
    Am J Cardiol; 1982 Apr; 49(6):1410-4. PubMed ID: 6176106
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibitors of the renin-angiotensin system. Effects on blood pressure, aldosterone secretion and renal function.
    Atlas SA; Niarchos AP; Case DB
    Am J Nephrol; 1983; 3(2-3):118-27. PubMed ID: 6191567
    [No Abstract]   [Full Text] [Related]  

  • 13. Proliferation of aortic smooth muscle cells and renin-angiotensin system in SHR rats.
    Wang XY; Wu KG; Jin XQ; Wang HJ
    Zhongguo Yao Li Xue Bao; 1998 Mar; 19(2):136-40. PubMed ID: 10374636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chronic captopril treatment on circulating and tissue renin-angiotensin system in SHR rats.
    Hu WY; Chen DG; Chen SC; Jin XQ; Wang HJ
    Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):507-12. PubMed ID: 9863143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
    Case DB; Wallace JM; Keim HJ; Weber MA; Drayer JI; White RP; Sealey JE; Laragh JH
    Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
    De Godoy MA; Rattan S
    J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of the renin-angiotensin system in the wall of rat femoral resistance vessels.
    Kvist S; Mulvany MJ; Aalkjaer C
    Eur J Pharmacol; 1991 May; 198(1):77-83. PubMed ID: 1915579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The renin-angiotensin system in different stages of spontaneous hypertension in the rat (S H R).
    Ruiz P; Basso N; Cannata MA; Taquini AC
    Clin Exp Hypertens A; 1990; 12(1):63-81. PubMed ID: 2407392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the brain renin-angiotensin system in the maintenance of blood pressure in conscious spontaneously hypertensive and sinoaortic baroreceptor-denervated rats.
    Paull JR; Bunting MW; Widdop RE
    Clin Exp Pharmacol Physiol; 1997; 24(9-10):667-72. PubMed ID: 9315367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renin inhibitor and converting enzyme inhibitors suppress vascular angiotensin II.
    Saito H; Nakamaru M; Ogihara T; Rakugi H; Kumahara Y; Shimamoto K; Miyazaki M; Inagami T
    Hypertension; 1989 Jun; 13(6 Pt 2):749-53. PubMed ID: 2661430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.